Related references
Note: Only part of the references are listed.New role of P2X7 receptor in an Alzheimer's disease mouse model
Elodie Martin et al.
MOLECULAR PSYCHIATRY (2019)
The P2X7 receptor: a new therapeutic target in Alzheimer's disease
Peter Illes et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease
Baban S. Thawkar et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis
Christopher M. Henstridge et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models
Martine Latta-Mahieu et al.
GLIA (2018)
Microglia in Alzheimer's disease
David V. Hansen et al.
JOURNAL OF CELL BIOLOGY (2018)
Untangling Genetic Risk for Alzheimer's Disease
Anna A. Pimenova et al.
BIOLOGICAL PSYCHIATRY (2018)
Targeting pattern-recognition receptors to discover new small molecule immune modulators
Gengzheng Zhu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and in vitro characterization of a P2X7 radioligand [123I] TZ6019 and its response to neuroinflammation in a mouse model of Alzheimer disease
Hongjun Jin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines
Denes Zadori et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant Trem2R47H on murine myeloid cell function
Qingwen Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2
Athena Sudom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry
Yoshio Muguruma et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
ApoE facilitates the microglial response to amyloid plaque pathology
Jason D. Ulrich et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Wilbur M. Song et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
Li Zhong et al.
MOLECULAR NEURODEGENERATION (2018)
Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence
Hamid Gholami Pourbadie et al.
NEUROBIOLOGY OF AGING (2018)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
C. Y. Daniel Lee et al.
NEURON (2018)
Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders
Anindya Bhattacharya
FRONTIERS IN PHARMACOLOGY (2018)
PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration
J. Obst et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)
Shabnam Shaabani et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology
Suresh B. Rangasamy et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed alpha-Synuclein Aggregation
Omid Tavassoly et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of β-amyloid
Ana Rubio-Araiz et al.
JOURNAL OF NEUROINFLAMMATION (2018)
TREM2-a key player in microglial biology and Alzheimer disease
Tyler K. Ulland et al.
NATURE REVIEWS NEUROLOGY (2018)
Inflammasome signalling in brain function and neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders
Anindya Bhattacharya et al.
PSYCHONEUROENDOCRINOLOGY (2018)
Microglia in Alzheimer's Disease: A Role for Ion Channels
Laura Thei et al.
FRONTIERS IN NEUROSCIENCE (2018)
Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
Joana R. Guedes et al.
FRONTIERS IN NEUROLOGY (2018)
Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
Sebastian Kobold et al.
FRONTIERS IN ONCOLOGY (2018)
High-affinity interactions and signal transduction between A beta oligomers and TREM2
Christian B. Lessard et al.
EMBO MOLECULAR MEDICINE (2018)
Meta-analysis of the association between CD33 and Alzheimer's disease
Yu-Ting Jiang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Yang Shi et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Small-Molecule TLR8 Antagonists via Structure-Based Rational Design
Zhenyi Hu et al.
CELL CHEMICAL BIOLOGY (2018)
Inhibition of the potassium channel KCa3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury
Roland G. W. Staal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Mechanisms and Therapeutic Relevance of Neuro-immune Communication
Sangeeta S. Chavan et al.
IMMUNITY (2017)
Kynurenine Pathway Metabolites in Alzheimer's Disease
Lasse Melvaer Giil et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
TREM2-Ligand Interactions in Health and Disease
Daniel L. Kober et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls
Celine Bellenguez et al.
NEUROBIOLOGY OF AGING (2017)
Senicapoc: Repurposing a Drug to Target Microglia KCa3.1 in Stroke
Roland G. W. Staal et al.
NEUROCHEMICAL RESEARCH (2017)
Elucidating the Role of TREM2 in Alzheimer's Disease
Jason D. Ulrich et al.
NEURON (2017)
Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures
Christopher J. Bohlen et al.
NEURON (2017)
Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions
Barbara Strasser et al.
NEUROPHARMACOLOGY (2017)
The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz et al.
NEUROPHARMACOLOGY (2017)
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
Michael D. Lovelace et al.
NEUROPHARMACOLOGY (2017)
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
Vincent Chouraki et al.
ALZHEIMERS & DEMENTIA (2017)
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant
Peter Thornton et al.
EMBO MOLECULAR MEDICINE (2017)
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
Kai Schlepckow et al.
EMBO MOLECULAR MEDICINE (2017)
The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease
Pinar Atukeren et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Inflammasome activation and innate immunity in Alzheimer's disease
Michael T. Heneka
BRAIN PATHOLOGY (2017)
Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
C. Dempsey et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease
Claudia Balducci et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Next Generation Transcriptomics and Genomics Elucidate Biological Complexity of Microglia in Health and Disease
Paul D. Wes et al.
GLIA (2016)
Central nervous system myeloid cells as drug targets: current status and translational challenges
Knut Biber et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Microglia in Health and Disease
Richard M. Ransohoff et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Oligodendrocyte Development and Plasticity
Dwight E. Bergles et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression
Michelle Go et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease
Claire L. McDonald et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
Nora Toeroek et al.
CURRENT DRUG METABOLISM (2016)
The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
Vahri Beaumont et al.
EXPERIMENTAL NEUROLOGY (2016)
The Microglial ATP-Gated Ion Channel P2X7 As a CNS Drug Target
Anindya Bhattacharya et al.
GLIA (2016)
KCa3.1-a Microglial Target Ready for Drug Repurposing?
Elena Dale et al.
GLIA (2016)
Glial Cells As Drug Targets What Does It Take?
Thomas Moller et al.
GLIA (2016)
Critical Data-Based Re-Evaluation of Minocycline as a Putative Specific Microglia Inhibitor
Thomas Moller et al.
GLIA (2016)
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Yaming Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Stimulation of TLR4 Attenuates Alzheimer's Disease-Related Symptoms and Pathology in Tau-Transgenic Mice
Yiren Qin et al.
JOURNAL OF IMMUNOLOGY (2016)
PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease
Kuti Baruch et al.
NATURE MEDICINE (2016)
Glia as drivers of abnormal neuronal activity
Stefanie Robel et al.
NATURE NEUROSCIENCE (2016)
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Marco Colonna et al.
NATURE REVIEWS NEUROSCIENCE (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
Felix L. Yeh et al.
NEURON (2016)
TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice
Teng Jiang et al.
NEUROPHARMACOLOGY (2016)
Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease
Lana M. Osborn et al.
PROGRESS IN NEUROBIOLOGY (2016)
Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
Daniel L. Kober et al.
ELIFE (2016)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
Reactive Astrogliosis: Role in Alzheimer's Disease
Priti Jain et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Glia in mammalian development and disease
J. Bradley Zuchero et al.
DEVELOPMENT (2015)
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Yuka Atagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Charles C. Bailey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species
Irene Lopez-Gonzalez et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
The promise and peril of chemical probes
Cheryl H. Arrowsmith et al.
NATURE CHEMICAL BIOLOGY (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
Douglas G. Walke et al.
NEUROBIOLOGY OF AGING (2015)
Elusive roles for reactive astrocytes in neurodegenerative diseases
Lucile Ben Haim et al.
Frontiers in Cellular Neuroscience (2015)
Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer's disease pathology
Kuti Baruch et al.
NATURE COMMUNICATIONS (2015)
Targeted Delivery of Protein and Gene Medicines Through the Blood-Brain Barrier
W. M. Pardridge
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Blood-Brain Barrier KCa3.1 Channels Evidence for a Role in Brain Na Uptake and Edema in Ischemic Stroke
Yi-Je Chen et al.
STROKE (2015)
Glia in the pathogenesis of neurodegenerative diseases
Alexei Verkhratsky et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Pattern recognition receptors and central nervous system repair
Kristina A. Kigerl et al.
EXPERIMENTAL NEUROLOGY (2014)
Siglec functions of microglia
Bettina Linnartz-Gerlach et al.
GLYCOBIOLOGY (2014)
CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimers disease susceptibility
Towfique Raj et al.
HUMAN MOLECULAR GENETICS (2014)
Priming of microglia in a DNA-repair deficient model of accelerated aging
Divya D. A. Raj et al.
NEUROBIOLOGY OF AGING (2014)
BRILLIANT BLUE G IMPROVES COGNITION IN AN ANIMAL MODEL OF ALZHEIMER'S DISEASE AND INHIBITS AMYLOID-β-INDUCED LOSS OF FILOPODIA AND DENDRITE SPINES IN HIPPOCAMPAL NEURONS
X. Chen et al.
NEUROSCIENCE (2014)
Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
Cory D. Rillahan et al.
CHEMICAL SCIENCE (2014)
Kynurenines in CNS disease: regulation by inflammatory cytokines
Brian M. Campbell et al.
FRONTIERS IN NEUROSCIENCE (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Rachael Bartlett et al.
PHARMACOLOGICAL REVIEWS (2014)
Bispecific antibodies for delivery into the brain
Ryan J. Watts et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Protein-protein interactions as druggable targets: recent technological advances
Alicia P. Higueruelo et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls
Markus J. Schwarz et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
CD33 Alzheimer's Risk-Altering Polymorphism, CD33 Expression, and Exon 2 Splicing
Manasi Malik et al.
JOURNAL OF NEUROSCIENCE (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al.
NATURE IMMUNOLOGY (2013)
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Elizabeth M. Bradshaw et al.
NATURE NEUROSCIENCE (2013)
Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Ana Griciuc et al.
NEURON (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain
Wei Wu et al.
PLOS ONE (2013)
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Amanda Sierra et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences
Eduardo Lopez-Collazo et al.
CRITICAL CARE (2013)
Innate immunity in the central nervous system
Richard M. Ransohoff et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
TLR2 Is a Primary Receptor for Alzheimer's Amyloid β Peptide To Trigger Neuroinflammatory Activation
Shirong Liu et al.
JOURNAL OF IMMUNOLOGY (2012)
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
Young-Jung Lee et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease
Wei Zhang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
Juan Ignacio Diaz-Hernandez et al.
NEUROBIOLOGY OF AGING (2012)
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia
Arny B. Dounay et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Ion channels and transporters in lymphocyte function and immunity
Stefan Feske et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Inflammatory Risk Factors and Pathologies Associated with Alzheimer's Disease
M. Sastre et al.
CURRENT ALZHEIMER RESEARCH (2011)
Microglial P2X7 receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease
Hwan Goo Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2011)
Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Huan Cao et al.
IMMUNOLOGY (2011)
Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity
Izumi Maezawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke
Yi-Je Chen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease
Min Song et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Inhibition of the Ca2+-Dependent K+ Channel, KCNN4/KCa3.1, Improves Tissue Protection and Locomotor Recovery after Spinal Cord Injury
Delphine Bouhy et al.
JOURNAL OF NEUROSCIENCE (2011)
TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
Naoko Matsunaga et al.
MOLECULAR PHARMACOLOGY (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
Kynurenine and its metabolites in Alzheimer's disease patients
E. Gulaj et al.
ADVANCES IN MEDICAL SCIENCES (2010)
The art of the chemical probe
Stephen V. Frye
NATURE CHEMICAL BIOLOGY (2010)
Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease
Oliver Wirths et al.
NEUROBIOLOGY OF AGING (2010)
Indoleamine 2,3-dioxygenase and 3-hydroxy-kynurenine modifications are found in the neuropathology of Alzheimer's disease
David J. Bonda et al.
REDOX REPORT (2010)
Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemia
Kenneth I. Ataga et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Natural ligands for CD33-related Siglecs?
Ajit Varki
GLYCOBIOLOGY (2009)
TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
Elsa-Noah N'Diaye et al.
JOURNAL OF CELL BIOLOGY (2009)
Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Juana M. Sanz et al.
JOURNAL OF IMMUNOLOGY (2009)
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
Maryse Letiembre et al.
NEUROBIOLOGY OF AGING (2009)
Microglial activation and amyloid deposition in mild cognitive impairment A PET study
A. Okello et al.
NEUROLOGY (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice
Stefanie Frank et al.
NEUROSCIENCE LETTERS (2009)
The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
Abdur Rahman et al.
PLOS ONE (2009)
Siglecs as targets for therapy in immune-cell-mediated disease
Mary K. O'Reilly et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
Kenneth I. Ataga et al.
BLOOD (2008)
Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer's Disease
Malabendu Jana et al.
JOURNAL OF IMMUNOLOGY (2008)
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation
Jae Woong Lee et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease
Karine L. Richard et al.
JOURNAL OF NEUROSCIENCE (2008)
TRAM-34 inhibits nonselective cation channels
Tom Schilling et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Microglial activation is required for Aβ clearance after intracranial injection of lipopolysaccharide in APP transgenic mice
Donna L. Herber et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis
Yang Zhang et al.
BIOCHEMISTRY (2007)
The Ca2+-activated K+ channel KCNN4/KCa3.1 contributes to microglia activation and nitric oxide-dependent neurodegeneration
Vikas Kaushal et al.
JOURNAL OF NEUROSCIENCE (2007)
Role of the toll-like receptor 4 in neuro-inflammation in Alzheimer's disease
Silke Walter et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry
Paolo Guidetti et al.
GLIA (2007)
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Zsuzsanna Hartai et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Role of toll-like receptor signalling in Aβ uptake and clearance
Kazuki Tahara et al.
BRAIN (2006)
Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus
James G. McLarnon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Dose-escalation study of ICA-17043 in patients with sickle cell disease
Kenneth I. Ataga et al.
PHARMACOTHERAPY (2006)
A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression
Annalisa Macagno et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Toll-like receptors in central nervous system glial inflammation and homeostasis
T Kielian
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide
KQ Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Y Liu et al.
BRAIN (2005)
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus
GJ Guillemin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2
K Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
JL Riley et al.
BLOOD (2005)
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling
F Lajaunias et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
JK Olson et al.
JOURNAL OF IMMUNOLOGY (2004)
A novel physiological mechanism of glycine-induced immunomodulation:: Na+-coupled amino acid transporter currents in cultured brain macrophages
T Schilling et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
AβI-42 induces production of quinolinic acid by human macrophages and microglia
GJ Guillemin et al.
NEUROREPORT (2003)
Role of toll-like receptors in pathogen recognition
S Janssens et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
P2X7 mediates superoxide production in primary microglia and is up-regulated in a Transgenic mouse model of Alzheimer's disease
LK Parvathenani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat
HQ Wu et al.
EXPERIMENTAL NEUROLOGY (2002)
Immunostimulatory CpG-DNA activates murine microglia
AH Dalpke et al.
JOURNAL OF IMMUNOLOGY (2002)
Lysophospholipids induce membrane hyperpolarization in microglia by activation of IKCa1Ca(2+)-dependent K+ channels
T Schilling et al.
NEUROSCIENCE (2002)
Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS
N Laflamme et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
G DiCarlo et al.
NEUROBIOLOGY OF AGING (2001)
K+ channels and the microglial respiratory burst
R Khanna et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components
N Laflamme et al.
FASEB JOURNAL (2001)
Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus
HQ Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Tryptophan degradation and immune activation in Alzheimer's disease
B Widner et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
